RCT to Evaluate STERN FIX Device As a Sternal Stabilization System in Patients After Sternotomy

Last updated: January 8, 2025
Sponsor: NEOS Surgery
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Combination of STERN FIX and wires

Wires

Clinical Study ID

NCT05953259
NEO-SC1-2023-01
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to compare the safety and performance of the sternal stabilization system STERN FIX with the standard of care (sternal closure with wires only) in normal conditions of use, in patients of risk undergoing median sternotomy during cardiothoracic surgery. The main question it aims to answer is:

• whether STERN FIX is a safe and efficient device to close the sternum after a sternotomy in patients of risk, achieving higher sternal stability than wires one month after surgery Participants will have their median sternotomy closed using STERN FIX in combination with wires or wires only at the end of their cardiothoracic surgery, according to the allocated treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient undergoing surgery that requires median sternotomy

  • Patients with at least one of the following risk criteria: obesity (BMI>30),diabetes, COPD, non serious osteoporosis (not associated with fractures), creatinine > 200 µmol/L and/or under dialysis treatment, scheduled Bilateral Internal MammaryArtery (BIMA) grafting

  • Patients willing and capable of granting informed consent to participate in clinicalresearch and who have granted written consent

  • Patient willing and capable of complying with the protocol requirements

Exclusion

Exclusion Criteria:

  • Patient with suspected or known allergies or intolerance to the device material (PEEK - polyether-ether-ketone and carbon fibre)

  • Patient with insufficient quality or quantity of bone or any other seriousstructural bone damage at the sternum

  • Patient with serious osteoporosis (associated with fractures) or a degenerative bonedisease affecting the sternum

  • Patients with a latent or active infection or inflammation at the surgical area,that according to the surgeon criteria may interfere in the device implantation orproper function.

  • Patient with sternal anomalies that, according to the surgeon criteria, prevent theuse of the product, such as bone tumours in the implantation area.

  • Pregnant patients or patients planning to become pregnant during the first 6 monthsafter surgery.

  • Patients with diagnosis of dementia with a mental status score (MMSE) < 20.

  • Patients with life expectancy lower than 6 months.

  • Patients involved in other interventionist clinical trials or that have beeninvolved in other interventionist clinical trials during the previous 4 weeks

  • Parasternal sternotomy.

  • Patients with intraoperative conditions that, according to the surgeon's opinion,require or exclude the use of a specific sternal closure system, or that cannot beclosed following the study products instructions for use.

IMPORTANT: When the allocated closure method is wires only, the surgeon must assess whether the patient could have also had STERN FIX implanted in order to decide if the patient can continue in the study.

Study Design

Total Participants: 90
Treatment Group(s): 2
Primary Treatment: Combination of STERN FIX and wires
Phase:
Study Start date:
September 27, 2023
Estimated Completion Date:
September 30, 2025

Connect with a study center

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, Baden-Württemberg 79106
    Germany

    Active - Recruiting

  • Complejo Hospitalario de Navarra

    Pamplona, Navarra 31008
    Spain

    Active - Recruiting

  • Hospital Clínic de Barcelona

    Barcelona, 08036
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.